DLAT and hepatocellular carcinoma: CDKN2A is mutated in 3 percent of HCC patients, MTF1 is mutated in 1 percent of HCC patients, and fewer mutations are found in GLS, LIPT1, and DLAT. The most abundant mutation type is the missense mutation (Figure 6(j)).